Moses Adondua Abah1,2, Micheal Abimbola Oladosu2,3, Akpi Uchenna Kalu4, Samuel Woyengibarakemi Ann5, Emmanuel Godwin Ogunjobi6, Eze Constance Nonye7, and Nathan Rimamsanati Yohanna1,2
DOI: https://doi.org/10.47587/MSA.2025.5401
1Department of Biochemistry, Faculty of Biosciences, Federal University Wukari, Taraba State, Nigeria
2ResearchHub Nexus Institute, Nigeria
3Department of Biochemistry, Faculty of Basic Medical Sciences, University of Lagos, Lagos State, Nigeria
4Department of Food Science, Universiti Kebabgsaan Malaysia,
5Department of Pharmacy, Faculty of Pharmacy, Niger Delta University Wilberforce Island Amassoma, PMB 071, Bayelsa State, Nigeria.
6Department of Microbiology, Faculty of Science, Adekunle Ajasin University, Ondo State, Nigeria
7Department of Biological Sciences, Southern Illinois University, Edwardsville, Illinois, United States of America
Received: Nov 12, 2025/ Revised: Dec 23, 2025/Accepted: Dec 25, 2025
(✉) Corresponding Author: : Moses Adondua Abah, m.abah@fuwukari.edu.ng
Highlights
-
Probiotics modulate gut microbiota to enhance nutrient digestion and metabolic efficiency
-
Microbial production of short-chain fatty acids regulates energy homeostasis and satiety hormones
-
SCFAs activate GPR41/GPR43, improving lipid metabolism and insulin sensitivity
-
Specific probiotic strains show benefits against obesity, inflammation, and metabolic dysfunction
-
Probiotics strengthen gut barrier function and reduce metabolic endotoxemia
Abstract
Probiotics, are live microorganisms that confer health benefits when administered in adequate amounts, play a pivotal role in nutrient metabolism through their modulation of the gut microbiota. By influencing the composition and activity of intestinal microbes, probiotics contribute to a more favorable gut environment that enhances digestive and metabolic processes. One of the key mechanisms underlying these effects is the production of short-chain fatty acids (SCFAs), such as acetate, propionate, and butyrate. These SCFAs, generated by the microbial fermentation of dietary fibers, serve not only as vital energy sources for colonic epithelial cells but also regulate systemic energy homeostasis. SCFAs have been documented to stimulate the secretion of hormones like glucagon-like peptide-1 (GLP-1) and peptide YY (PYY), which together enhance satiety, promote optimal glucose metabolism, and suppress appetite. This review delves into the multifaceted roles of probiotics and gut microbiota in nutrient metabolism. Emerging research highlights that probiotics can improve metabolic health by reducing visceral fat accumulation, improving glucose metabolism, and alleviating inflammation associated with obesity. Notably, specific strains such as Lactobacillus gasseri SBT2055, Bifidobacterium breve B-3, and Akkermansia muciniphila have demonstrated significant beneficial effects in experimental and clinical studies. The SCFAs produced by these probiotics activate G-protein-coupled receptors, including GPR41 and GPR43, modulating lipid metabolism, enhancing insulin sensitivity, and increasing overall energy expenditure. Moreover, probiotics fortify gut barrier function, reduce metabolic endotoxemia, and enhance the thickness of the intestinal mucus layer, thereby improving glucose tolerance and reducing adiposity. Collectively, these findings underscore the potential of probiotics as a valuable adjunct therapy for metabolic health. By supporting nutrient metabolism through multiple mechanisms such as modulation of gut microbiota, SCFA production, and regulation of energy balance. Probiotics offer promising avenues for the prevention and management of metabolic disorders like obesity and type 2 diabetes making them a valuable adjunct therapy for metabolic health.
Keywords: Probiotics, Gut microbiota, Nutrient metabolism, Short-chain fatty acids, Obesity, and Inflammation
References
Bäckhed, F., Roswall, J., Peng, Y., Feng, Q., Jia, H., Kovatcheva-Datchary, P., … Jun, W. (2015). Dynamics and stabilization of the human gut microbiome during the first year of life. Cell Host & Microbe, 17(5), 690–703.
Bergström, A., Skov, T. H., Bahl, M. I., Roager, H. M., Christensen, L. B., Ejlerskov, K. T., Licht, T. R. (2014). Establishment of intestinal microbiota during early life: a longitudinal, explorative study of a large cohort of Danish infants. Applied and Environmental Microbiology, 80(9), 2889–2900.
Bron, P. A., van Baarlen, P., & Kleerebezem, M. (2012). Emerging molecular insights into the interaction between probiotics and the host intestinal mucosa. Nature Reviews Microbiology, 10(1), 66–78.
Canfora, E. E., & Blaak, E. E. (2020). Towards personalized microbial substrates for metabolic health. Nature Reviews Endocrinology, 16(8), 495–496.
Corr, S. C., Li, Y., Riedel, C. U., O’Toole, P. W., Hill, C., & Gahan, C. G. M. (2007). Bacteriocin production as a mechanism for the antiinfective activity of Lactobacillus salivarius UCC118. Proceedings of the National Academy of Sciences, 104(18),
Corrêa-Oliveira, R., Fachi, J. L., Vieira, A., Sato, F. T., & Vinolo, M. A. R. (2016). Regulation of immune cell function by short-chain fatty acids. Clinical & Translational Immunology, 5(4), e73.
Cristofori, F., Dargenio, V. N., Dargenio, C., Miniello, V. L., & Francavilla, R. (2021). Anti-inflammatory and immunomodulatory effects of probiotics in gut disorders: A new era in microbiota therapy. Biomedicine, 9(7), 759.
David, L. A., Maurice, C. F., Carmody, R. N., Gootenberg, D. B., Button, J. E., Wolfe, B. E., Turnbaugh, P. J. (2014). Diet rapidly and reproducibly alters the human gut microbiome. Nature, 505(7484), 559–563.
De Filippo, C., Cavalieri, D., Di Paola, M., Ramazzotti, M., Poullet, J. B., Massart, S., … Lionetti, P. (2010). Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. Proceedings of the National Academy of Sciences, 107(33), 14691–14696.
Dinan, T. G., & Cryan, J. F. (2017). Gut instincts: microbiota as a key regulator of brain development, ageing and neurodegeneration. The Journal of Physiology, 595(2), 489–503.
Dominguez-Bello, M. G., Costello, E. K., Contreras, M., Magris, M., Hidalgo, G., Fierer, N., & Knight, R. (2010). Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns. Proceedings of the National Academy of Sciences, 107(26), 11971–11975.
Ejtahed, H. S., Angoorani, P., Hasani-Ranjbar, S., & Larijani, B. (2020). Probiotics and their potential role in metabolic syndrome: A systematic review. Iranian Journal of Basic Medical Sciences, 23(11), 1416–1424.
Falony, G., Joossens, M., Vieira-Silva, S., Wang, J., Darzi, Y., Faust, K., … Raes, J. (2016). Population-level analysis of gut microbiome variation. Nature, 535(7613), 75–84.
Fan, Y., & Pedersen, O. (2021). Gut microbiota in human metabolic health and disease. Nature Reviews Microbiology, 19(1), 55–71.
Gao, Y., Lin, J., Ye, C., Guo, S., & Jiang, C. (2022). Microbial transformations of bile acids and their receptors in metabolic dysfunction-associated steatotic liver disease. Liver Research, 6(1), 1–12.
Hill, C., Guarner, F., Reid, G., Gibson, G. R., Merenstein, D. J., Pot, B., … Sanders, M. E. (2014). Expert consensus document: The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nature Reviews Gastroenterology & Hepatology, 11(8), 506–514.
Hylemon, P. B. (2023). The Hylemon–Björkhem pathway of bile acid 7-dehydroxylation: History, biochemistry, and microbiology. Journal of Lipid Research, 64(8), 100392.
John, G. K., Wang, L., Nanavati, J., Twose, C., Singh, R., & Mullin, G. (2020). Dietary alteration of the gut microbiome and its impact on weight and fat mass: A systematic review and meta-analysis. Genes, 11(7), 807
Kobyliak, N., Conte, C., & Cammarota, G. (2016). Probiotics in prevention and treatment of obesity: A critical view. Nutrition & Metabolism, 13, 14.
Kumar, M., Nagpal, R., Hemalatha, R., Verma, V., Kumar, A., & Aggarwal, P. K. (2020). Probiotic metabolites as epigenetic targets in the prevention of colon cancer. Nutrition Reviews, 78(6), 486–497.
Lebeer, S., Vanderleyden, J., & De Keersmaecker, S. C. J. (2008). Genes and molecules of Lactobacillus supporting probiotic action. Microbiology and Molecular Biology Reviews, 72(4), 728–764. https://doi.org/10.1128/MMBR.00017-08
Markowiak, P., & Śliżewska, K. (2020). Effects of probiotics, prebiotics, and synbiotics on human health: A review. Nutrients, 12(4), 1261. https://doi.org/10.3390/nu12041261
Mimee, M., Citorik, R. J., & Lu, T. K. (2018). Microbiome therapeutics: Advances and challenges. Nature Reviews Drug Discovery, 17(6), 365–377. https://doi.org/10.1038/nrd.2018.32
O’Callaghan, A., & van Sinderen, D. (2016). Bifidobacteria and their role as members of the human gut microbiota. Frontiers in Microbiology, 7, 925. https://doi.org/10.3389/fmicb.2016.00925
Ouwehand, A. C., & Forssten, S. D. (2020). Probiotic research trends: A bibliometric analysis. Beneficial Microbes, 11(5), 415–426.
Ridlon, J. M., Kang, D. J., & Hylemon, P. B. (2006). Bile salt biotransformations by human intestinal bacteria. Journal of Lipid Research, 47(2), 241–259.
Sanders, M. E., Merenstein, D. J., Reid, G., Gibson, G. R., & Rastall, R. A. (2019). Probiotics and prebiotics in intestinal health and disease: From biology to the clinic. Nature Reviews Gastroenterology & Hepatology, 16(10), 605–616.
Segers, M. E., & Lebeer, S. (2014). Towards a better understanding of Lactobacillus rhamnosus GG—host interactions. Microbial Cell Factories, 13, S7.
Shao, Y., Forster, S. C., Tsaliki, E., Vervier, K., Strang, A., Simpson, N., … Lawley, T. D. (2019). Stunted microbiota and opportunistic pathogen colonization in caesarean-section birth. Nature, 574(7776), 117–121. https://doi.org/10.1038/s41586-019-1560-1
Sonnenburg, E. D., & Sonnenburg, J. L. (2014). Starving our microbial self: The deleterious consequences of a diet deficient in microbiota-accessible carbohydrates. Cell Metabolism, 20(5), 779–786. https://doi.org/10.1016/j.cmet.2014.07.003
Tan, J., McKenzie, C., Potamitis, M., Thorburn, A. N., Mackay, C. R., & Macia, L. (2014). The role of short-chain fatty acids in health and disease. Advances in Immunology, 121, 91–119.
World Health Organization (2022). WHO recommendations for care of the preterm or low-birth-weight infant. Geneva: WHO Press. Available at: WHO publication
Wu, G. D., Chen, J., Hoffmann, C., Bittinger, K., Chen, Y. Y., Keilbaugh, S. A., … Lewis, J. D. (2011). Linking long-term dietary patterns with gut microbial enterotypes. Science, 334(6052), 105–108. https://doi.org/10.1126/science.1208344
Yatsunenko, T., Rey, F. E., Manary, M. J., Trehan, I., Dominguez-Bello, M. G., Contreras, M., … Gordon, J. I. (2012). Human gut microbiome viewed across age and geography. Nature, 486(7402), 222–227.
Zhang, C., Yin, A., Li, H., Wang, R., Wu, G., Shen, J., … Zhao, G. (2020). Dietary modulation of gut microbiota contributes to alleviation of both genetic and environmental risk of obesity.Published in Nature Metabolism, 2(6), 605–617
Zhang, T., Li, Q., Cheng, L., Buch, H., & Zhang, F. (2021). Advances in microbiome research and precision nutrition. Frontiers in Genetics, 12, 682.
How to cite this article
Adondua Abah, M., Oladosu, M. A., Kalu, A. U., Ann, S. W., Ogunjobi, E. G., Nonye, E. C., & Yohanna, N. R. (2025). The role of probiotics and gut microbiota in nutrient metabolism. Microbial Science Archives, 5(4), 31–41. https://doi.org/10.47587/MSA.2025.5401
Licence Article Metadata
This work is licensed under a Creative Commons Attribution 4.0 International License.
![]()









